CervoMed Inc. - 8-K Filing
CervoMed Inc. filed an 8-K on June 18, 2026, announcing a registered direct offering where it agreed to sell 2,500,000 shares of common stock at $4.00 per share for gross proceeds of $10.0 million before fees and expenses. The company also entered into an engagement letter with H.C. Wainwright & Co., LLC as placement agent, who will receive a 6% cash fee and warrants to purchase 6% of the shares issued in the offering. Additionally, CervoMed agreed not to issue equity or file registration statements during a 30-day lock-up period following closing. (Items: 1.01 Entry into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $CRVO